Value In Health features TRANSPERS papers and commentary on assessing the value of precision medicine and other Big Data technologies

The world has entered the "Information Age" for health care. In this world, everything is connected and the integration of "Big Data" - characterized by high velocity, volume, and variety - is increasingly important. Yet this growth in technologies must be integrated into a health care system that is undergoing fundamental change. A commentary and series of papers by TRANSPERS collaborators and other authors (organized by TRANSPERS Director Kathryn Phillips) offers insights into these trends and their implications for assessing value. The papers incorporate a wide range of perspectives - patients, providers, health care systems, society - but they all focus on the overarching issue of how to appropriately consider and assess the value of new technologies.

• Phillips KA. Assessing the value and implications of personalized/precision medicine and the "lessons learned" for emerging technologies: An Introduction. Value Health. 2017; 20: 30-31.
• Phillips KA, Douglas MP, Trosman JR, et al. "What Goes Around Comes Around": Lessons Learned from Economic Evaluations of Personalized Medicine Applied to Digital Medicine. Value Health. 2017; 20: 47-53.
• Marshall DA, Gonzalez JM, MacDonald KV, et al. Estimating Preferences for Complex Health Technologies: Lessons Learned and Implications for Personalized Medicine. Value Health 2017; 20: 32-39.
• Trosman JR, Weldon CB, Douglas MP, et al. Decision-Making on Medical Innovations in a Changing Health Environment: Insights from Accountable Care Organizations and Payers on Personalized Medicine and Other Technologies. Value Health. 2017; 20: 40-46.
• Rosenman MB, Decker B, Levy KD, et al. Lessons learned when introducing pharmacogenomic panel testing into clinical practice Value Health. 2017; 20: 54-59.